The monthly intravenous treatment is designed to slow cognitive decline, but whether that is the case remains so unclear that the FDA approved the medication on a different basis — its ability to reduce amyloid beta plaque in the brain.
See Original Article

Noir ensures timely bookkeeping and credible accounting with unmatched accuracy through state-of-the-art software. The company even offers
See Original Article

Sonali Basak, Bloomberg Wall Street Reporter, discusses private equity buyouts in light of Medline's recent deal. Hosted by Paul Sweeney and Matt
See Original Article

Microstrategy already owns 92,079 Bitcoins, worth more than $3 billion at current prices. Bitcoin was trading at $35,800 on Monday. Microstrategy’s purchases come even as the firm also said in a separate securities filing that it …
See Original Article

The pandemic upended the work environment last year, with many employees, including accountants and tax professionals, forced to work remotely.
See Original Article